V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003111 | 210011491 | 1.61 | 56.9 | null | null | 2018-08-18 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100304112 |
| 210003112 | 210011492 | null | 83.5 | Adjuvant (A) | null | 2019-10-07 | Trastuzumab | null | N | TRASTUZUMAB | 100070955 |
| 210003113 | 210011493 | 1.59 | 55.6 | Disease modification (D) | null | 2022-05-04 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100480015 |
| 210003114 | 210011494 | 1.62 | null | Palliative (P) | 2020-08-18 | 2020-08-18 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101455719 |
| 210003116 | 210011495 | 1.6 | 98.8 | Palliative (P) | 2021-05-08 | 2021-05-24 | Paclitaxel 7 day | 01 | N | PACLITAXEL | 100706292 |
| 210003120 | 210011498 | null | 75 | null | 2020-03-24 | 2020-03-28 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 101240640 |
| 210003121 | 210011499 | 1.69 | 65 | Adjuvant (A) | 2021-12-03 | 2021-12-22 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100552009 |
| 210003129 | 210011500 | 1.68 | 58 | null | null | 2020-01-24 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101151851 |
| 210003135 | 210011501 | 1.76 | 67.4 | Palliative (P) | 2017-04-20 | 2017-09-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101066007 |
| 210003138 | 210011504 | 1.59 | null | null | 2018-09-22 | 2018-10-10 | Docetaxel | null | null | DOCETAXEL | 100463305 |
| 210003139 | 210011505 | 1.76 | 85.7 | null | null | 2017-12-23 | Paclitaxel 7 day | null | null | PACLITAXEL | 100747922 |
| 210003144 | 210011506 | 1.71 | 55.3 | Adjuvant (A) | 2017-04-30 | 2020-12-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100904106 |
| 210003147 | 210011508 | 1.58 | 67.4 | Palliative (P) | 2018-06-20 | 2018-11-28 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101213383 |
| 210003148 | 210011509 | 1.75 | 60 | null | 2020-06-03 | 2020-06-11 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100550953 |
| 210003151 | 210011512 | 1.58 | 63.5 | Adjuvant (A) | null | 2018-08-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100910185 |
| 210003152 | 210011513 | 1.68 | null | null | 2021-09-08 | 2021-10-07 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101399222 |
| 210003153 | 210011514 | 1.7 | null | null | 2019-11-18 | 2020-01-27 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 101127410 |
| 210003158 | 210011515 | 1.61 | 39.5 | Palliative (P) | 2021-05-13 | 2021-08-14 | Trastuzumab | null | N | TRASTUZUMAB | 100735496 |
| 210003159 | 210011516 | 1.69 | 79.3 | null | 2018-04-25 | 2018-04-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101854038 |
| 210003162 | 210011517 | null | null | null | null | 2016-08-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100331511 |
| 210003164 | 210011518 | null | null | Palliative (P) | 2017-12-24 | 2017-12-31 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100322804 |
| 210003166 | 210011519 | 1.56 | 59.4 | Adjuvant (A) | 2020-11-26 | 2021-04-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100079108 |
| 210003167 | 210011520 | 1.65 | 104.9 | Palliative (P) | 2019-09-10 | 2019-09-19 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100092492 |
| 210003168 | 210011521 | null | 73.2 | Adjuvant (A) | 2020-03-10 | 2020-04-01 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101593551 |
| 210003173 | 210011522 | 1.63 | 115 | Neo-adjuvant (N) | 2020-06-20 | 2020-07-05 | Docetaxel | 01 | N | DOCETAXEL | 101675931 |
| 210003177 | 210011523 | 1.55 | null | null | null | 2019-05-05 | Trastuzumab | null | null | TRASTUZUMAB | 100715959 |
| 210003179 | 210011524 | 1.69 | 60.5 | null | 2019-08-23 | 2019-08-25 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100324559 |
| 210003181 | 210011525 | 1.54 | 88.1 | Palliative (P) | 2021-01-20 | 2021-01-20 | Docetaxel | 02 | N | DOCETAXEL | 100302192 |
| 210003184 | 210011526 | 1.61 | 65 | Adjuvant (A) | 2018-07-30 | 2019-12-13 | Docetaxel | 02 | N | DOCETAXEL | 100356887 |
| 210003186 | 210011527 | 0 | 106 | null | null | 2021-01-06 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101501469 |
| 210003189 | 210011528 | 1.58 | 54.1 | Adjuvant (A) | 2018-10-23 | 2019-01-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100328559 |
| 210003190 | 210011529 | 1.51 | 62 | null | null | 2019-01-10 | Trastuzumab | 02 | null | TRASTUZUMAB | 100503820 |
| 210003193 | 210011530 | 1.59 | 104.6 | Adjuvant (A) | null | 2018-11-22 | Docetaxel | 02 | N | DOCETAXEL | 101684009 |
| 210003194 | 210011531 | 1.54 | 80.9 | Adjuvant (A) | 2019-06-26 | 2019-07-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101493971 |
| 210003195 | 210011532 | 1.75 | 65 | Adjuvant (A) | null | 2018-10-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101518937 |
| 210003199 | 210011534 | 1.64 | 63.2 | null | 2017-08-18 | 2017-09-02 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100272287 |
| 210003203 | 210011535 | 1.54 | 52.8 | Adjuvant (A) | 2021-03-31 | 2021-06-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 101584040 |
| 210003204 | 210011536 | 1.65 | 69 | null | 2017-06-11 | 2017-07-03 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100067574 |
| 210003209 | 210011538 | 1.58 | 102.85 | Palliative (P) | 2020-02-13 | 2020-02-14 | Eribulin | null | N | ERIBULIN | 101497595 |
| 210003216 | 210011539 | 1.71 | 120.15 | Neo-adjuvant (N) | 2019-10-31 | 2020-01-16 | Eribulin | 02 | Y | ERIBULIN | 100277260 |
| 210003217 | 210011540 | 1.62 | 66.3 | null | null | 2021-04-02 | null | 02 | null | EPIRUBICIN | 100329896 |
| 210003218 | 210011541 | 1.71 | 122.6 | Adjuvant (A) | 2019-01-06 | 2019-04-06 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101162900 |
| 210003220 | 210011542 | 1.6 | 79.1 | Neo-adjuvant (N) | 2017-12-25 | 2018-01-21 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100029122 |
| 210003221 | 210011543 | 1.69 | 58 | Neo-adjuvant (N) | 2020-06-05 | 2020-08-29 | Palbociclib | 02 | N | CARBOPLATIN + PACLITAXEL | 100633312 |
| 210003222 | 210011544 | null | null | null | 2021-02-10 | 2021-09-12 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 100507774 |
| 210003223 | 210011545 | 1.72 | 65.2 | Palliative (P) | 2017-05-17 | 2017-05-26 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101712169 |
| 210003225 | 210011547 | null | null | null | 2018-02-02 | 2018-02-22 | Capecitabine | null | null | CAPECITABINE | 101114576 |
| 210003226 | 210011548 | 1.61 | 53.7 | Palliative (P) | 2019-12-06 | 2019-12-12 | Eribulin | 02 | N | ERIBULIN | 100456723 |
| 210003228 | 210011549 | 1.62 | 71.9 | Neo-adjuvant (N) | 2018-07-15 | 2018-07-20 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101095975 |
| 210003232 | 210011550 | 1.73 | 115 | Palliative (P) | 2019-05-12 | 2019-05-22 | null | null | N | PALBOCICLIB | 100731432 |